Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE
The role of salvage high-dose chemotherapy and autologous stem cell transplantation (sHDCT/ASCT) for relapsed and/or refractory multiple myeloma (RRMM) in the era of continuous novel agent treatment has not been defined. This randomized, open-label, phase III, multicenter trial randomized patients w...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
21 July 2020
|
| In: |
Leukemia
Year: 2021, Jahrgang: 35, Heft: 4, Pages: 1134-1144 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/s41375-020-0948-0 |
| Online-Zugang: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41375-020-0948-0 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41375-020-0948-0 
|
| Verfasserangaben: | Hartmut Goldschmidt, Marc-Andrea Baertsch, Jana Schlenzka, Natalia Becker, Christina Habermehl, Thomas Hielscher, Marc-Steffen Raab, Jens Hillengass, Sandra Sauer, Carsten Müller-Tidow, Steffen Luntz, Anna Jauch, Dirk Hose, Anja Seckinger, Peter Brossart, Martin Goerner, Stefan Klein, Martin Schmidt-Hieber, Peter Reimer, Ullrich Graeven, Roland Fenk, Mathias Haenel, Hans Martin, Hans W. Lindemann, Christoph Scheid, Axel Nogai, Hans Salwender, Richard Noppeney, Britta Besemer, Katja Weisel |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1725647060 | ||
| 003 | DE-627 | ||
| 005 | 20230426183825.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200728s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41375-020-0948-0 |2 doi | |
| 035 | |a (DE-627)1725647060 | ||
| 035 | |a (DE-599)KXP1725647060 | ||
| 035 | |a (OCoLC)1341347945 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 245 | 1 | 0 | |a Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma |b the randomized GMMG phase III trial ReLApsE |c Hartmut Goldschmidt, Marc-Andrea Baertsch, Jana Schlenzka, Natalia Becker, Christina Habermehl, Thomas Hielscher, Marc-Steffen Raab, Jens Hillengass, Sandra Sauer, Carsten Müller-Tidow, Steffen Luntz, Anna Jauch, Dirk Hose, Anja Seckinger, Peter Brossart, Martin Goerner, Stefan Klein, Martin Schmidt-Hieber, Peter Reimer, Ullrich Graeven, Roland Fenk, Mathias Haenel, Hans Martin, Hans W. Lindemann, Christoph Scheid, Axel Nogai, Hans Salwender, Richard Noppeney, Britta Besemer, Katja Weisel |
| 264 | 1 | |c 21 July 2020 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 28.07.2020 | ||
| 520 | |a The role of salvage high-dose chemotherapy and autologous stem cell transplantation (sHDCT/ASCT) for relapsed and/or refractory multiple myeloma (RRMM) in the era of continuous novel agent treatment has not been defined. This randomized, open-label, phase III, multicenter trial randomized patients with 1st-3rd relapse of multiple myeloma (MM) to a transplant arm (n = 139) consisting of 3 Rd (lenalidomide 25 mg, day 1-21; dexamethasone 40 mg, day 1, 8, 15, and 22; 4-week cycles) reinduction cycles, sHDCT (melphalan 200 mg/m2), ASCT, and lenalidomide maintenance (10 mg/day) or to a control arm (n = 138) of continuous Rd. Median PFS was 20.7 months in the transplant and 18.8 months in the control arm (HR 0.87; 95% CI 0.65-1.16; p = 0.34). Median OS was not reached in the transplant and 62.7 months in the control arm (HR 0.81; 95% CI 0.52-1.28; p = 0.37). Forty-one patients (29%) did not receive the assigned sHDCT/ASCT mainly due to early disease progression, adverse events, and withdrawal of consent. Multivariate landmark analyses from the time of sHDCT showed superior PFS and OS (p = 0.0087/0.0057) in patients who received sHDCT/ASCT. Incorporation of sHDCT/ASCT into relapse treatment with Rd was feasible in 71% of patients and did not significantly prolong PFS and OS on ITT analysis while patients who received sHDCT/ASCT may have benefitted. | ||
| 700 | 1 | |a Bärtsch, Marc-Andrea |d 1988- |e VerfasserIn |0 (DE-588)1099464854 |0 (DE-627)858599074 |0 (DE-576)469306505 |4 aut | |
| 700 | 1 | |a Schlenzka, Jana |d 1971- |e VerfasserIn |0 (DE-588)122728513 |0 (DE-627)70601782X |0 (DE-576)293397163 |4 aut | |
| 700 | 1 | |a Becker, Natalia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Habermehl, Christina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hielscher, Thomas |e VerfasserIn |0 (DE-588)1159594791 |0 (DE-627)1022977768 |0 (DE-576)50506068X |4 aut | |
| 700 | 1 | |a Raab, Marc-Steffen |d 1973- |e VerfasserIn |0 (DE-588)124052460 |0 (DE-627)706520998 |0 (DE-576)293998027 |4 aut | |
| 700 | 1 | |a Hillengaß, Jens |d 1974- |e VerfasserIn |0 (DE-588)124918549 |0 (DE-627)368073823 |0 (DE-576)294568298 |4 aut | |
| 700 | 1 | |a Sauer, Sandra |d 1975- |e VerfasserIn |0 (DE-588)1060031140 |0 (DE-627)799171778 |0 (DE-576)416132855 |4 aut | |
| 700 | 1 | |a Müller-Tidow, Carsten |d 1968- |e VerfasserIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 aut | |
| 700 | 1 | |a Luntz, Steffen P. |d 1968- |e VerfasserIn |0 (DE-588)120890216 |0 (DE-627)70506624X |0 (DE-576)292433077 |4 aut | |
| 700 | 1 | |a Jauch, Anna |d 1959- |e VerfasserIn |0 (DE-588)1025525140 |0 (DE-627)722525362 |0 (DE-576)168357496 |4 aut | |
| 700 | 1 | |a Hose, Dirk |d 1969- |e VerfasserIn |0 (DE-588)139824995 |0 (DE-627)613790308 |0 (DE-576)313431698 |4 aut | |
| 700 | 1 | |a Seckinger, Anja |d 1980- |e VerfasserIn |0 (DE-588)134177371 |0 (DE-627)562118225 |0 (DE-576)278603734 |4 aut | |
| 700 | 1 | |a Brossart, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goerner, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klein, Stefan |e VerfasserIn |0 (DE-588)1042491836 |0 (DE-627)769066372 |0 (DE-576)393988791 |4 aut | |
| 700 | 1 | |a Schmidt-Hieber, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Reimer, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Graeven, Ullrich |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fenk, Roland |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haenel, Mathias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Martin, Hans |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lindemann, Hans W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Scheid, Christoph |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nogai, Axel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Salwender, Hans |e VerfasserIn |4 aut | |
| 700 | 1 | |a Noppeney, Richard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Besemer, Britta |e VerfasserIn |4 aut | |
| 700 | 1 | |a Weisel, Katja |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1997 |g 35(2021), 4, Seite 1134-1144 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma the randomized GMMG phase III trial ReLApsE |
| 773 | 1 | 8 | |g volume:35 |g year:2021 |g number:4 |g pages:1134-1144 |g extent:11 |a Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma the randomized GMMG phase III trial ReLApsE |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41375-020-0948-0 |x Resolving-System |x Verlag |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41375-020-0948-0 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200728 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 1042491836 |a Klein, Stefan |m 1042491836:Klein, Stefan |d 60000 |d 61200 |e 60000PK1042491836 |e 61200PK1042491836 |k 0/60000/ |k 1/60000/61200/ |p 17 | ||
| 998 | |g 134177371 |a Seckinger, Anja |m 134177371:Seckinger, Anja |p 14 | ||
| 998 | |g 139824995 |a Hose, Dirk |m 139824995:Hose, Dirk |d 50000 |e 50000PH139824995 |k 0/50000/ |p 13 | ||
| 998 | |g 1025525140 |a Jauch, Anna |m 1025525140:Jauch, Anna |d 910000 |d 911500 |e 910000PJ1025525140 |e 911500PJ1025525140 |k 0/910000/ |k 1/910000/911500/ |p 12 | ||
| 998 | |g 120890216 |a Luntz, Steffen P. |m 120890216:Luntz, Steffen P. |d 910000 |d 913000 |e 910000PL120890216 |e 913000PL120890216 |k 0/910000/ |k 1/910000/913000/ |p 11 | ||
| 998 | |g 1015101798 |a Müller-Tidow, Carsten |m 1015101798:Müller-Tidow, Carsten |d 910000 |d 910100 |e 910000PM1015101798 |e 910100PM1015101798 |k 0/910000/ |k 1/910000/910100/ |p 10 | ||
| 998 | |g 1060031140 |a Sauer, Sandra |m 1060031140:Sauer, Sandra |d 910000 |d 910100 |e 910000PS1060031140 |e 910100PS1060031140 |k 0/910000/ |k 1/910000/910100/ |p 9 | ||
| 998 | |g 124918549 |a Hillengaß, Jens |m 124918549:Hillengaß, Jens |d 910000 |d 910100 |e 910000PH124918549 |e 910100PH124918549 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 998 | |g 124052460 |a Raab, Marc-Steffen |m 124052460:Raab, Marc-Steffen |d 910000 |d 910100 |e 910000PR124052460 |e 910100PR124052460 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 1159594791 |a Hielscher, Thomas |m 1159594791:Hielscher, Thomas |d 140000 |e 140000PH1159594791 |k 0/140000/ |p 6 | ||
| 998 | |g 122728513 |a Schlenzka, Jana |m 122728513:Schlenzka, Jana |d 910000 |d 910100 |e 910000PS122728513 |e 910100PS122728513 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1099464854 |a Bärtsch, Marc-Andrea |m 1099464854:Bärtsch, Marc-Andrea |d 910000 |d 910100 |e 910000PB1099464854 |e 910100PB1099464854 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |e 910000PG102258023X |e 910100PG102258023X |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1725647060 |e 373089594X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Hartmut Goldschmidt, Marc-Andrea Baertsch, Jana Schlenzka, Natalia Becker, Christina Habermehl, Thomas Hielscher, Marc-Steffen Raab, Jens Hillengass, Sandra Sauer, Carsten Müller-Tidow, Steffen Luntz, Anna Jauch, Dirk Hose, Anja Seckinger, Peter Brossart, Martin Goerner, Stefan Klein, Martin Schmidt-Hieber, Peter Reimer, Ullrich Graeven, Roland Fenk, Mathias Haenel, Hans Martin, Hans W. Lindemann, Christoph Scheid, Axel Nogai, Hans Salwender, Richard Noppeney, Britta Besemer, Katja Weisel"]},"id":{"doi":["10.1038/s41375-020-0948-0"],"eki":["1725647060"]},"physDesc":[{"extent":"11 S."}],"recId":"1725647060","origin":[{"dateIssuedDisp":"21 July 2020","dateIssuedKey":"2020"}],"person":[{"family":"Goldschmidt","given":"Hartmut","role":"aut","display":"Goldschmidt, Hartmut"},{"family":"Bärtsch","given":"Marc-Andrea","role":"aut","display":"Bärtsch, Marc-Andrea"},{"display":"Schlenzka, Jana","family":"Schlenzka","role":"aut","given":"Jana"},{"given":"Natalia","role":"aut","family":"Becker","display":"Becker, Natalia"},{"family":"Habermehl","role":"aut","given":"Christina","display":"Habermehl, Christina"},{"display":"Hielscher, Thomas","given":"Thomas","role":"aut","family":"Hielscher"},{"display":"Raab, Marc-Steffen","family":"Raab","role":"aut","given":"Marc-Steffen"},{"role":"aut","given":"Jens","family":"Hillengaß","display":"Hillengaß, Jens"},{"family":"Sauer","role":"aut","given":"Sandra","display":"Sauer, Sandra"},{"family":"Müller-Tidow","given":"Carsten","role":"aut","display":"Müller-Tidow, Carsten"},{"display":"Luntz, Steffen P.","role":"aut","given":"Steffen P.","family":"Luntz"},{"display":"Jauch, Anna","role":"aut","given":"Anna","family":"Jauch"},{"display":"Hose, Dirk","given":"Dirk","role":"aut","family":"Hose"},{"display":"Seckinger, Anja","family":"Seckinger","given":"Anja","role":"aut"},{"display":"Brossart, Peter","family":"Brossart","given":"Peter","role":"aut"},{"family":"Goerner","role":"aut","given":"Martin","display":"Goerner, Martin"},{"display":"Klein, Stefan","family":"Klein","role":"aut","given":"Stefan"},{"display":"Schmidt-Hieber, Martin","role":"aut","given":"Martin","family":"Schmidt-Hieber"},{"display":"Reimer, Peter","given":"Peter","role":"aut","family":"Reimer"},{"display":"Graeven, Ullrich","family":"Graeven","given":"Ullrich","role":"aut"},{"display":"Fenk, Roland","role":"aut","given":"Roland","family":"Fenk"},{"role":"aut","given":"Mathias","family":"Haenel","display":"Haenel, Mathias"},{"display":"Martin, Hans","family":"Martin","given":"Hans","role":"aut"},{"given":"Hans W.","role":"aut","family":"Lindemann","display":"Lindemann, Hans W."},{"family":"Scheid","given":"Christoph","role":"aut","display":"Scheid, Christoph"},{"display":"Nogai, Axel","family":"Nogai","given":"Axel","role":"aut"},{"given":"Hans","role":"aut","family":"Salwender","display":"Salwender, Hans"},{"display":"Noppeney, Richard","family":"Noppeney","role":"aut","given":"Richard"},{"display":"Besemer, Britta","role":"aut","given":"Britta","family":"Besemer"},{"role":"aut","given":"Katja","family":"Weisel","display":"Weisel, Katja"}],"relHost":[{"recId":"32046699X","physDesc":[{"extent":"Online-Ressource"}],"disp":"Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma the randomized GMMG phase III trial ReLApsELeukemia","pubHistory":["Nachgewiesen 11.1997 -"],"origin":[{"dateIssuedKey":"1997","dateIssuedDisp":"1997-","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group"}],"part":{"year":"2021","volume":"35","pages":"1134-1144","extent":"11","text":"35(2021), 4, Seite 1134-1144","issue":"4"},"title":[{"subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia","title_sort":"Leukemia"}],"id":{"eki":["32046699X"],"issn":["1476-5551"],"zdb":["2008023-2"]},"note":["Gesehen am 15.03.04"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"note":["Gesehen am 28.07.2020"],"title":[{"title_sort":"Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma","title":"Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma","subtitle":"the randomized GMMG phase III trial ReLApsE"}]} | ||
| SRT | |a GOLDSCHMIDSALVAGEAUT2120 | ||